Evidence map›Paper›PMID 37236775›Full record

ArticleBMJ evidence-based medicine2023

Metro Mapping: development of an innovative methodology to co-design care paths to support shared decision making in oncology.

Anne Stiggelbout, Ingeborg Griffioen, Jasper Brands, Marijke Melles, Judith Rietjens, Marleen Kunneman, Marion van der Kolk, Casper van Eijck, Dirk Snelders

Abstract read
In one paragraph

Article in BMJ evidence-based medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Observational
  3. The value of FOLFIRINOX in advanced pancreatic cancer: balancing efficacy, toxicity, and quality of life.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anne StiggelboutMedical Decision Making, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands a.m.stiggelbout@lumc.nl.ORCID 0000-0002-6293-4509
Ingeborg GriffioenMedical Decision Making, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
Jasper BrandsDesign Studio Panton, Deventer, The Netherlands.
Marijke MellesDepartment of Human-Centered Design, Faculty of Industrial Design Engineering, Delft University of Technology, Delft, The Netherlands.
Judith RietjensDepartment of Design, Organisation and Strategy, Faculty of Industrial Design Engineering, Delft University of Technology, Delft, The Netherlands.
Marleen KunnemanMedical Decision Making, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0001-5334-1085
Marion van der KolkDepartment of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
Casper van EijckDepartment of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
Dirk SneldersDepartment of Design, Organisation and Strategy, Faculty of Industrial Design Engineering, Delft University of Technology, Delft, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Decision Making, SharedMedical OncologyHumansPatient Care PlanningClinical Decision-MakingHealth Services ResearchONCOLOGYPatient CareQuality of Health Care

Identifiers

PMID37236775
PMCPMC10579511

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.